NLS Pharmaceutics Ltd. Gains 21.56%
Wed, Sep 07, 2022 at 07:24 PM

NLS Pharmaceutics Ltd. (NLSP:NASDAQ) shot up at $0.73, representing a gain of 21.6%. On Wed, Sep 07, 2022, NLSP:NASDAQ touched a New 2-Week High of $0.73. From Wed, Aug 24, 2022, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Mon, Aug 22, 2022 at $0.77 with a volume of 3M+.
About NLS Pharmaceutics Ltd. (NLSP:NASDAQ)
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders.
Top 10 Gainers:
- IMARA Inc. (IMRA:NASDAQ), 74.78%
- Azure Power Global Limited (AZRE:NYSE), 35.38%
- SelectQuote Inc. (SLQT:NYSE), 28.83%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 27.72%
- Spero Therapeutics, Inc. (SPRO:NASDAQ), 26.55%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 23.73%
- Pingtan Marine Enterprise Ltd. (PME:NASDAQ), 23.26%
- Nutex Health Inc. (NUTX:NASDAQ), 21.92%
- Molecular Templates, Inc. (MTEM:NASDAQ), 21.83%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 21.56%